Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00739830
Recruitment Status : Completed
First Posted : August 22, 2008
Last Update Posted : July 1, 2015
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.